Acadia Healthcare (NASDAQ:ACHC) Stock Price Passes Above 200-Day Moving Average – Time to Sell?

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s stock price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $20.04 and traded as high as $25.19. Acadia Healthcare shares last traded at $24.60, with a volume of 1,898,373 shares changing hands.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on the company. TD Cowen upped their price target on Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a report on Tuesday, April 28th. Royal Bank Of Canada upped their price target on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. Cantor Fitzgerald upped their price target on Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a report on Friday, May 1st. Barclays upped their price target on Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Thursday, April 30th. Finally, Zacks Research raised Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. One analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat, Acadia Healthcare has an average rating of “Hold” and an average price target of $26.85.

Acadia Healthcare Stock Performance

The business has a fifty day simple moving average of $25.52 and a two-hundred day simple moving average of $20.04. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. The company has a market cap of $2.26 billion, a P/E ratio of -2.01, a P/E/G ratio of 8.30 and a beta of 0.69.

Acadia Healthcare (NASDAQ:ACHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. During the same quarter in the prior year, the company earned $0.40 earnings per share. Acadia Healthcare’s revenue was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, sell-side analysts anticipate that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in ACHC. Goldman Sachs Group Inc. raised its stake in shares of Acadia Healthcare by 417.8% in the fourth quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after buying an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. bought a new position in shares of Acadia Healthcare in the fourth quarter worth about $47,960,000. Wellington Management Group LLP raised its stake in shares of Acadia Healthcare by 24.9% in the fourth quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after buying an additional 2,350,760 shares during the period. Vaughan Nelson Investment Management L.P. bought a new position in shares of Acadia Healthcare in the first quarter worth about $43,017,000. Finally, Invenomic Capital Management LP grew its position in shares of Acadia Healthcare by 71.0% during the fourth quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock worth $46,998,000 after purchasing an additional 1,375,647 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.